<img height="1" width="1" style="display:none;" alt="" src="https://px.ads.linkedin.com/collect/?pid=2653956&amp;fmt=gif">
Image Overlay - Eli Lilly Begins Phase III Clinical Trial for Coronavirus
Image Overlay - Eli Lilly Begins Phase III Clinical Trial for Coronavirus

Eli Lilly Begins Phase III Clinical Trial for Coronavirus

June 24, 2020

Eli Lilly Begins Phase III Clinical Trial for Coronavirus

The company has begun phase III clinical trials for Olumiant, which is an approved treatment for rheumatoid arthritis. The company will enroll 400 patients in the U.S., Europe, and Latin America in the trial for the potential coronavirus treatment. With depots across Latin America and Europe and headquarters in the U.S., Yourway is equipped to service global clinical trials.

Back to Index
Stay Connected

Want to stay informed about the latest news, updates, and opportunities at Yourway?

Join our newsletter mailing list to never miss an update!

Media

Upcoming Events

Clinical Trial Supply Europe

February 24-26, 2026
Hyatt Regency, Barcelona Tower

Global Clinical Supplies Group Asia Pacific Conference

March 10-12, 2026
Conrad Seoul Hotel, South Korea

Media

Articles

Why Integration Matters in Clinical Supply Chains

Open chat
Come chat with us!
Hello! How can I help you?